Semaglutide and beyond: a turning point in obesity pharmacotherapy
Lancet Reg Health Eur
.
2024 Feb 1:37:100860.
doi: 10.1016/j.lanepe.2024.100860.
eCollection 2024 Feb.
Author
The Lancet Regional Health-Europe
PMID:
38362559
PMCID:
PMC10866919
DOI:
10.1016/j.lanepe.2024.100860
No abstract available
Publication types
Editorial
Comment